Is a complete SCNX research report available?

No complete published report is available for Scienture Holdings, Inc. (SCNX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Scienture Holdings, Inc. (SCNX)

NASDAQ: SCNX · USD

$3.20

-0.03 (-1.1%)· Recorded snapshot

Market cap	5.2M
Revenue (ttm)	821.3K
Net income (ttm)	-38M
EPS (ttm)	-$32.5
Shares out	1.6M
Volume	40,595
Beta	4.08

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 821.3K
Net income (ttm): -38M
EPS (ttm): -$32.5
Market cap: 5.2M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Trzymaj

Metric	Value
Amount currency	USD
CIK code	0001382574
Company name	Scienture Holdings, Inc.
Country	United States
Country code	US
CUSIP number	80880X203
Earnings date	2026-11-12
Earnings time	bmo
Employees	9
Employees change	-10
Employees growth	-52.63%
Enterprise value	$7.7M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2010
Industry	Pharmaceutical Retailers
IPO date	2020-02-13
Is primary listing	Yes
Is SPAC	No
ISIN number	US80880X2036
Last 10-K release date	2026-03-30
Last earnings date	2026-08-14
Last refreshed	2026-10-28
Last stock split date	2026-10-05
Last stock split type	Reverse
Market cap	$5.2M
Market cap category	Nano-Cap
Next earnings date	2026-11-12
Options	No
Price	$3.20
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	SCNX
U.S. state	New York
Website	https://scienture.com

Metric

Value

Amount currency

USD

CIK code

0001382574

Company name

Scienture Holdings, Inc.

Country

United States

Country code

CUSIP number

80880X203

Earnings date

2026-11-12

Earnings time

bmo

Employees

Employees change

-10

Employees growth

-52.63%

Enterprise value

$7.7M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2010

Industry

Pharmaceutical Retailers

IPO date

2020-02-13

Is primary listing

Yes

Is SPAC

ISIN number

US80880X2036

Last 10-K release date

2026-03-30

Last earnings date

2026-08-14

Last refreshed

2026-10-28

Last stock split date

2026-10-05

Last stock split type

Reverse

Market cap

$5.2M

Market cap category

Nano-Cap

Next earnings date

2026-11-12

Options

Price

$3.20

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

SCNX

U.S. state

New York

Website

https://scienture.com

Metric	Value
Earnings yield	-1,015.85%
EV/Sales	9.51x
FCF / EV yield	-184.97%
FCF yield	-272.18%
Forward EV/Sales	2.17x
Forward P/S	1.47x
P/B ratio	0.08x
P/S ratio	6.46x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Earnings yield

-1,015.85%

EV/Sales

9.51x

FCF / EV yield

-184.97%

FCF yield

-272.18%

Forward EV/Sales

2.17x

Forward P/S

1.47x

P/B ratio

0.08x

P/S ratio

6.46x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
Gross margin	87.72%
Operating margin	-1,671.08%
Pretax margin	-4,863.81%
Profit per employee	$-4.2M
Revenue per employee	$91,257
ROA	-8.93%
ROCE	-16.2%
ROE	-53.47%
ROIC	-10.94%
SBC / revenue	321.51%
Tax / revenue	-242.89%

Metric

Value

Gross margin

87.72%

Operating margin

-1,671.08%

Pretax margin

-4,863.81%

Profit per employee

$-4.2M

Revenue per employee

$91,257

ROA

-8.93%

ROCE

-16.2%

ROE

-53.47%

ROIC

-10.94%

SBC / revenue

321.51%

Tax / revenue

-242.89%

Metric	Value
EPS growth quarters	5
EPS growth years	0
Gross profit growth	9,660.71%
Net income growth quarters	1
Net income growth years	0
Revenue growth	540.64%
Revenue growth (QoQ)	510.1%
Revenue growth years	1

Metric

Value

EPS growth quarters

EPS growth years

Gross profit growth

9,660.71%

Net income growth quarters

Net income growth years

Revenue growth

540.64%

Revenue growth (QoQ)

510.1%

Revenue growth years

Metric	Value
Depreciation and amortization	$1.4M
EBIT	$-13.7M
EBITDA	$-12.4M
EPS	$-32.46
FCF per share	$-8.79
Financing cash flow	$25.6M
Free cash flow	$-14.4M
Free cash flow minus SBC	$-17.1M
Gross profit	$720,438
Income taxes	$-2M
Net borrowing	$4.3M
Net cash flow	$11.2M
Net income	$-38M
Operating cash flow minus SBC	$-17.1M
Operating income	$-13.7M
Revenue	$821,315
Stock-based compensation	$2.6M

Metric

Value

Depreciation and amortization

$1.4M

EBIT

$-13.7M

EBITDA

$-12.4M

EPS

$-32.46

FCF per share

$-8.79

Financing cash flow

$25.6M

Free cash flow

$-14.4M

Free cash flow minus SBC

$-17.1M

Gross profit

$720,438

Income taxes

$-2M

Net borrowing

$4.3M

Net cash flow

$11.2M

Net income

$-38M

Operating cash flow minus SBC

$-17.1M

Operating income

$-13.7M

Revenue

$821,315

Stock-based compensation

$2.6M

Metric	Value
Altman Z-Score	-1.29
Book value per share	$39.03
Debt / equity	0.17
Interest coverage	-4.48
Long-term assets	$78.5M
Long-term liabilities	$20.6M
Net cash (debt)	$-2.5M
Net cash / market cap	-47.15%
Net debt / equity	0.04
Piotroski F-Score	4
Property, plant and equipment	$16,968
Shareholders' equity	$64.1M
Tangible book value	$-6M
Tangible book value per share	$-3.63
Total assets	$87.7M
Total cash	$8.2M
Total debt	$10.7M
Total liabilities	$23.6M
WACC	24%

Metric

Value

Altman Z-Score

-1.29

Book value per share

$39.03

Debt / equity

0.17

Interest coverage

-4.48

Long-term assets

$78.5M

Long-term liabilities

$20.6M

Net cash (debt)

$-2.5M

Net cash / market cap

-47.15%

Net debt / equity

0.04

Piotroski F-Score

Property, plant and equipment

$16,968

Shareholders' equity

$64.1M

Tangible book value

$-6M

Tangible book value per share

$-3.63

Total assets

$87.7M

Total cash

$8.2M

Total debt

$10.7M

Total liabilities

$23.6M

WACC

24%

Metric	Value
Asset turnover	0.01
Current assets	$9.2M
Current liabilities	$3M
Current ratio	3.04
Net working capital	$-891,648
Quick ratio	2.83
Working capital	$6.2M
Working capital turnover	-2.5

Metric

Value

Asset turnover

0.01

Current assets

$9.2M

Current liabilities

$3M

Current ratio

3.04

Net working capital

$-891,648

Quick ratio

2.83

Working capital

$6.2M

Working capital turnover

-2.5

Metric	Value
Buyback yield / dilution	-236.59%
Dividend yield	0%
Shareholder yield	-236.59%

Metric

Value

Buyback yield / dilution

-236.59%

Dividend yield

Shareholder yield

-236.59%

Metric	Value
150-day SMA	$8.59
1D price change	-1.08%
1M price change	-53.93%
1M total return	-53.93%
1W price change	9.98%
1W total return	9.98%
1Y price change	-88.49%
1Y return CAGR	-88.5%
1Y total return	-88.49%
20-day SMA	$3.44
200-day SMA	$9.28
3M price change	-65.19%
3M total return	-65.19%
50-day SMA	$6.66
50-day SMA vs 200-day SMA	50under200
52-week high	$30.45
52-week high date	2025-10-28
52-week low	$2.64
52-week low date	2026-10-23
6M price change	-66.47%
6M total return	-66.47%
All-time high	$335.50
All-time high date	2024-07-29
All-time low	$2.64
All-time low date	2026-10-23
Average true range (ATR)	$0.45
Average volume	411.8K
Beta (1Y)	1.52
Beta (2Y)	2.78
Beta (5Y)	4.08
Change from 52-week high	-89.51%
Change from 52-week low	21.02%
Change from all-time high	-99.05%
Change from all-time low	21.02%
Change from open	0%
Day's gap	-1.08%
Dollar volume	$129,701
High price	$3.20
Low price	$3.20
Monthly RSI	10.64
Open price	$3.20
Premarket change	-6.81%
Premarket close	$3.23
Premarket price	$3.01
Previous close	$3.23
Price vs 150-day SMA	-62.8%
Price vs 20-day SMA	-7.04%
Price vs 200-day SMA	-65.58%
Price vs 50-day SMA	-52.03%
Relative volume	0.1
RSI	28.96
Sharpe ratio	-1.68
Sortino ratio	-2.08
Volume	40.6K
Weekly RSI	28.73
YTD price change	-74.94%
YTD total return	-74.94%

Metric

Value

150-day SMA

$8.59

1D price change

-1.08%

1M price change

-53.93%

1M total return

-53.93%

1W price change

9.98%

1W total return

9.98%

1Y price change

-88.49%

1Y return CAGR

-88.5%

1Y total return

-88.49%

20-day SMA

$3.44

200-day SMA

$9.28

3M price change

-65.19%

3M total return

-65.19%

50-day SMA

$6.66

50-day SMA vs 200-day SMA

50under200

52-week high

$30.45

52-week high date

2025-10-28

52-week low

$2.64

52-week low date

2026-10-23

6M price change

-66.47%

6M total return

-66.47%

All-time high

$335.50

All-time high date

2024-07-29

All-time low

$2.64

All-time low date

2026-10-23

Average true range (ATR)

$0.45

Average volume

411.8K

Beta (1Y)

1.52

Beta (2Y)

2.78

Beta (5Y)

4.08

Change from 52-week high

-89.51%

Change from 52-week low

21.02%

Change from all-time high

-99.05%

Change from all-time low

21.02%

Change from open

Day's gap

-1.08%

Dollar volume

$129,701

High price

$3.20

Low price

$3.20

Monthly RSI

10.64

Open price

$3.20

Premarket change

-6.81%

Premarket close

$3.23

Premarket price

$3.01

Previous close

$3.23

Price vs 150-day SMA

-62.8%

Price vs 20-day SMA

-7.04%

Price vs 200-day SMA

-65.58%

Price vs 50-day SMA

-52.03%

Relative volume

0.1

RSI

28.96

Sharpe ratio

-1.68

Sortino ratio

-2.08

Volume

40.6K

Weekly RSI

28.73

YTD price change

-74.94%

YTD total return

-74.94%

Metric	Value
Float	1.3M
Float percentage	77.92%
Shares change (QoQ)	-2.5%
Shares change (YoY)	236.59%
Shares held by insiders	22.08%
Shares held by institutions	7.89%
Shares outstanding	1.6M
Short % of shares	79.4%
Short ratio	0.9 days

Metric

Value

Float

1.3M

Float percentage

77.92%

Shares change (QoQ)

-2.5%

Shares change (YoY)

236.59%

Shares held by insiders

22.08%

Shares held by institutions

7.89%

Shares outstanding

1.6M

Short % of shares

79.4%

Short ratio

0.9 days

Scienture Holdings, Inc. (SCNX)

Price

Financial snapshot

Fair-value bridge

Latest news · SCNX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SCNX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SCNX

Frequently asked questions